Buyouts to increase in consumer, pharma, tech sectors in 2014: KPMGs M&A Predictor
As Indian economy shows signs of bottoming out, analysts expect 2014 to be a much better year with increased M&A sentiment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Venus Remedies receives Indonesian GMP certification for its Baddi unit
The GMP approval will soon pave way for marketing authorisations from Indonesia; Venus expecting registrations for 10 oncology…
Mylan launches first trastuzumab biosimilar, Hertraz, in India
Its indicated for the treatment of HER2-positive metastatic breast cancer and is available in two strengths
Gilead names Mylan as exclusive branded medicines business partner for India
Under the agreement, Mylan will market and distribute in India certain Gilead medications
Pharmaceuticals exports to overtake domestic sales in FY15: Ind-Ra
Exports are likely to overtake domestic market sales in FY15, according to the rating agency
Generic opportunities in developed markets pivotal for Indian pharmas performance: ICRA
As far as the emerging markets are concerned certain regulatory developments in some of the markets have hindered the growth…
Venus Remedies bags US patent for Achnil
Developed by Venus Medicine Research Centre it will be commercialised in US market through technology transfer/outlicensing of…
SPARC gets DCGI nod for breast cancer injection paclitaxel
As a part of the arrangement, SPARC is eligible for milestone and royalty income
Expansion of product pipelines towards complementary offerings drive M&A activity
Indian pharma sector witnesses no deals during January 2014